Search
Iovance Biotherapeutics Inc
IOVAAdd to Watchlist
3.970USD
-0.190-4.57%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
1.77BMarket Cap
LossP/E TTM
Iovance Biotherapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
263.50M
60.60%
EPS(YoY)
-1.09
14.78%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its total revenue reached 263.50M, with a year-on-year change of 60.60.
What are the current assets of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its current assets were 442.69M, with a year-on-year change of -3.14.
What are the total assets of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its total assets of Iovance Biotherapeutics Inc were 913.17M, with a year-on-year change of 0.30.
What are the total liabilities of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its total liabilities of Iovance Biotherapeutics Inc were 214.59M, with a year-on-year change of 7.28.
What is the total equity of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its total equity of Iovance Biotherapeutics Inc was 698.58M, with a year-on-year change of -1.66.
What is the net investment of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its net investment of Iovance Biotherapeutics Inc was 47.50M, with a year-on-year change of 149.26.
What is the net financing of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its net financing of Iovance Biotherapeutics Inc was 300.77M, with a year-on-year change of -23.01.
What is the Earnings Per Share (EPS) of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.09, with a year-on-year change of 14.78.
What is the net margin of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its net profit margin was -148.38, with a year-on-year change of 34.59.
What is the gross margin of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its gross margin was 20.64, with a year-on-year change of -15.51.
What is the debt-to-asset ratio of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.11, with a year-on-year change of -0.30.
What is the Return on Equity (ROE) of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -55.50, with a year-on-year change of 3.45.
What is the Return on Assets (ROA) of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -42.88, with a year-on-year change of 2.60.
What is the operating profit of Iovance Biotherapeutics Inc?
According to Iovance Biotherapeutics Inc's FY2025 earnings report, its operating profit was -398.21M, with a year-on-year change of -2.66.